{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:22:57Z","timestamp":1765617777145,"version":"3.48.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arcmed.2025.103338","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T20:01:02Z","timestamp":1764446462000},"page":"103338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Evaluation of Seronegative Celiac Disease"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-9292","authenticated-orcid":false,"given":"Andrew","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-4203","authenticated-orcid":false,"given":"Claire","family":"Jansson-Knodell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Rubio-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103338_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0300-2977(98)00050-3","article-title":"SAT and serology in adult coeliacs, seronegative coeliac disease seems a reality","volume":"53","author":"Rostami","year":"1998","journal-title":"Neth J Med"},{"key":"10.1016\/j.arcmed.2025.103338_bib0002","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1023\/B:DDAS.0000026296.02308.00","article-title":"Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy","volume":"49","author":"Abrams","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2025.103338_bib0003","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOG.0000000000000436","article-title":"Seronegative coeliac disease: clearing the diagnostic dilemma","volume":"34","author":"Schiepatti","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ajg.2013.45","article-title":"Villous atrophy and negative serology: a diagnostic and therapeutic dilemma","volume":"108","author":"DeGaetani","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0005","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/gutjnl-2016-312271","article-title":"The clinical and phenotypical assessment of seronegative villous atrophy; a prospected UK centre experience evaluating 200 cases over a 15-year period (2000\u20132015)","volume":"66","author":"Aziz","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103338_bib0006","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/apt.16599","article-title":"Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study","volume":"54","author":"Schiepatti","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2025.103338_bib0007","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1136\/gutjnl-2021-326645","article-title":"Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris Consensus","volume":"71","author":"Schiepatti","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103338_bib0008","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/imj.12716","article-title":"Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective","volume":"45","author":"Tye-Din","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.arcmed.2025.103338_bib0009","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mayocp.2017.10.025","article-title":"Not all that flattens villi is celiac disease: a review of enteropathies","volume":"93","author":"Jansson-Knodell","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.arcmed.2025.103338_bib0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.14309\/ajg.0000000000000575","article-title":"Management of small bowel villous atrophy in patients seronegative for celiac disease","volume":"115","author":"Jansson-Knodell","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cei\/uxab010","article-title":"Intestinal anti-tissue transglutaminase IgA deposits as a complimentary method for diagnostic evaluation of celiac disease in patients with low-grade lesions","volume":"3","author":"Roca","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0012","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4049\/jimmunol.166.6.4170","article-title":"Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease","volume":"166","author":"Marzari","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0013","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm.2656","article-title":"High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions","volume":"18","author":"Di Niro","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2025.103338_bib0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cei.13078","article-title":"Intestinal transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study","volume":"191","author":"Borrelli","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.14309\/ajg.0000000000002105","article-title":"Rapid immunochromatography on fresh intestinal biopsy is highly accurate in detecting intestinal antitransglutaminase antibodies","volume":"118","author":"Lega","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0016","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/db08-0962","article-title":"Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine","volume":"58","author":"Maglio","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2025.103338_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ restricted T cells isolated from the small intestinal mucosa of celiac disease patients","author":"Lundin","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2025.103338_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1542-3565(05)00532-X","article-title":"Celiac disease genetics: current concepts and practical applications","volume":"3","author":"Sollid","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0019","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/ajg.2011.23","article-title":"Assessing possible celiac disease by an HLA-DQ2-gliadin tetramer test","author":"Brottveit","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0020","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2025.103338_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734763","article-title":"Circulating miRNAs as potential biomarkers for celiac disease development","volume":"12","author":"Tan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0022","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1007\/s10620-019-05966-z","article-title":"A miRNA-based blood and mucosal approach for detecting and monitoring celiac disease","volume":"65","author":"Bascunan","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2025.103338_bib0023","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1007\/s11033-023-08394-5","article-title":"Expression analysis of IL-2, TBX21, and SOCS1 in peripheral blood cells of celiac disease patients reveals the diagnostic potential of IL-2","volume":"50","author":"Ganjali","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.arcmed.2025.103338_bib0024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14309\/ajg.0000000000001565","article-title":"Plasma IL-2 and symptoms response after acute gluten exposure in subjects with celiac disease or nonceliac gluten sensitivity","volume":"117","author":"Cartee","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cei.13578","article-title":"Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease","volume":"204","author":"Anderson","year":"2021","journal-title":"Clin Exp Imunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0026","first-page":"1","article-title":"Genetic and flow cytometry analysis of seronegative celiac disease: a cohort study","volume":"54","author":"Leon","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/flgastro-2021-101838","article-title":"Diagnosis of celiac disease by flow cytometry of intraepithelial lymphocytes: a new \u2018gold\u2019 standard?","volume":"13","author":"Basu","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1081955","article-title":"Intestinal and blood lymphograms as new diagnostic tests for celiac disease","volume":"13","author":"Roy","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103338_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50735-7","article-title":"A phospholipid profile at 4 months predicts the onset of celiac disease in at-risk infants","volume":"9","author":"Auricchio","year":"2019","journal-title":"Sci rep"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:20:24Z","timestamp":1765617624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0188440925001584"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103338","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Evaluation of Seronegative Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103338"}}